Oregon Health and Science University

  • Image

    OREGON HEALTH & SCIENCE UNIVERSITY

    Our mission is to enhance the efficiency and quality of rigorously translating research ideas into impact.
  • Oregon's CTSA hub, the Oregon Clinical and Translational Research Institute (OCTRI), accelerates innovation at Oregon Health and Science Univeristy (OHSU) with pilot funding, project management, and entrepreneur education. OCTRI's Biomedical Innovation Program (BIP), which includes pilot funds and project management support, was featured in the 2022 OHSU Innovates Impact Report. OCTRI is
  • Oregon's CTSA Hub, the Oregon Clinical and Translational Research Institute (OCTRI), is a hub for the expertise and physical resources that researchers, clinicians, and community partners need to develop impactful health care interventions based on scientific discoveries. The $48 million Clinical and Translational Science Award (CTSA) to Oregon Health and Science University from the NIH National
  • Oregon Health and Science University

    An important untapped resource for clinical trial and research recruitment is community-based primary care centers, including rural health clinics, federally-qualified health centers and other community health centers. These centers are where many receive care, often from diverse populations underrepresented in clinical research. Despite this promise, there are notable barriers to conducting

  • Two recipients of the 2022 NIH Director’s Early Independence Award (EIA) were supported by the Oregon Clinical and Translational Research Institute (OCTRI) at the Oregon Health & Science University (OHSU). Former OCTRI TL1 awardee, Mary Willis, PhD, received the EIA for her work on the impact of pollution from gas and oil development on fertility and pregnancy. Dr. Willis is currently an Assistant
  • OCTRI* Recruitment and Special Populations Program Manager, Meredith Zauflik, MPA, represents the research rank team members on the Covington Response Oversight Committee at Oregon Health and Science University (OHSU). This committee was formed in response to a report commissioned by OHSU leadership to assess institutional culture and recommend transformative changes. Ms. Zauflik was recently
  • OHSU* Senior Director for Collaboration & Entrepreneurship and OCTRI** Director of Innovation Programs and Awards, Aditi Martin, PhD, co-authored an article for Oregon Business magazine about cultivating diversity and inclusion in business and innovation environments, based upon her work at OCTRI and OHSU. She co-wrote the op-ed with Graciela Gomez Cowger, JD, CEO of Schwabe, Williamson, and Wyatt
  • In collaboration with OHSU Innovates, the Oregon Clinical and Translational Research Institute (OCTRI) announced two new funded projects for the 2022 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology projects, including validation of drug targets and development of small molecules, antibodies, vaccines
  • Oregon Health and Science University Logo
    -
    Oregon Health and Science University
    The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
  • Oregon Health and Science University Logo
    -
    Oregon Health and Science University

    The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will

  • Oregon Health and Science University Logo
    -
    Oregon Health and Science University

    The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will

  • Oregon Health and Science University

    What does business have to do with translation? According to Balas and Boren, the gap between discovery and clinical practice, is on average, 17 years! A variety of factors contribute to this gap, but a general lack of support beyond funding is significant and persistent. CTSAs have looked to novel methods to provide this support including commercialization-focused programs for investigators

  • OHSU startup, Inherent Targeting, is among the Pacific Northwest-based startups selected to present at the Pacific Northwest Startup Showcase & Social on Tuesday, October 12 from 10am-12pm. Inherent Targeting improves surgical outcomes with high contrast, nerve-specific fluorescent dyes that help surgeons visualize buried nerves and distinguish them from surrounding tissue. This reduces patient
  • In 2020, the Oregon Clinical & Translational Research Institute (OCTRI) awarded Jessica Grant, an OHSU speech therapist, and David Sheridan, MD, an OCTRI Scholar and OHSU associate professor of emergency medicine, a Biomedical Innovation Program award for their device called the Koala Kushion. This week, the duo was interviewed for OHSU's Innovator Spotlight series. Read more about their progress
  • In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced three new funded projects for the 2021 drug discovery track of the Biomedical Innovation Program. This program supports drug discovery platforms and early-stage therapeutic technology
  • Oregon Health and Science University
    Case report Forms (CRFs) are standardized documents in which the study team records data collected in a clinical trial. CRFs should support compliant collection and documentation of research data by following Good Clinical Practice and Good Documentation guidelines. This seminar will cover definitions, operational considerations, and data requirements, while focusing on data outputs (data analysis
  • Oregon Health and Science University
    This class will cover the most common questions regarding survey design and administration - and provide the answers! Topics we will cover include: Writing great survey questions Choosing previously validated questions Selecting survey software and administration methods Maximizing response rates Budgeting for your survey Designing your survey to facilitate data analysis Piloting your survey. We
  • Oregon Health and Science University
    Subject Injuries are adverse experiences that arise directly from or contributed to by the study drug(s), study device(s), or study procedures that would not have been expected from the standard treatment for the patient's condition, progression of condition, or other reasons. This training introduces the topics of subject injuries, ethical positions, informed consent language, and clinical
  • Image of a machine head with DNA bases flowing out the back.
    -
    Oregon Health and Science University
    This meeting is organized and hosted by the Genomic Data Science Working Group of the National Human Genome Research Institute (NHGRI). The primary purpose of the workshop is to stimulate discussion around the opportunities and obstacles underlying the application of machine learning (ML) methods to basic genome sciences and genomic medicine, to define the key scientific topic areas in genomics
  • OCTRI Scholar Dr. David Sheridan (left) and Dr. Matthew Hansen (right), both OHSU Emergency Medicine physicians, were awarded OCTRI Biomedical Innovation Program (BIP) funding and project support in 2018 to develop a new bedside technology for quickly detecting sepsis using an accurate and objective measure of capillary refill time (CRT). In the last 3 years, Drs. Sheridan and Hansen leveraged
  • A team of researchers led by Dr. Dora M. Raymaker, one of few openly autistic researchers, used a community-based participatory research (CBPR) approach to conduct an inaugural study on autistic burnout. Findings draw attention to the syndrome, long recognized by autistic people but not formally investigated, and will inform future research, prevention strategies, and interventions. Autistic
  • In collaboration with the Technology Transfer and Collaborations & Entrepreneurship offices at Oregon Health & Science University (OHSU), the Oregon Clinical and Translational Research Institute (OCTRI) announced four new funded projects for the 2021 device and diagnostics track of the Biomedical Innovation Program. This program cultivates, evaluates, and funds promising translational projects
  • Urea Cycle Disorders Consortium

    Urea cycle disorders (UCDs) are rare but devastating genetic conditions. In 2003, the Urea Cycle Disorders Consortium (UCDC) became one of the first members of the RDCRN. Since then, UCDC has flourished into an international network of 16 academic centers in the United States, Canada and Europe that provide state-of-the-art care and conduct cutting-edge clinical research. The UCDC is currently

  • Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

    The Phenylalanine Families and Researchers Exploring Evidence (PHEFREE) Consortium studies the health, neurologic, cognitive, neuropsychiatric, patient-reported and quality-of-life outcomes in individuals with chronic elevations of the amino acid phenylalanine in blood (hyperphenylalaninemia). In the United States, elevated blood phenylalanine is typically detected at birth through newborn

  • Virginia Commonwealth University
    University of Nebraska Medical Center
    University Of Washington
    University Of Alabama At Birmingham
    University Of North Carolina Chapel Hill
    Johns Hopkins University
    Mayo Clinic
    Oregon Health and Science University

    Many clinical questions have arisen with the COVID-19 pandemic, from who is at greatest risk for COVID-19 infection to adverse outcomes if infected to how COVID-19 has impacted healthcare utilization patterns. To help answer these questions, and many more, the National COVID Cohort Collaborative (N3C) has integrated real-world clinical observations from across the nation into a harmonized database

  • Brittle Bone Disorders Consortium (BBD)
    Brittle bone disorders (BBDs), also known as osteogenesis imperfecta, include 13 inherited conditions involving bones that break easily. Brittle bone disorders can cause deformity and chronic pain and lead to premature death. The Brittle Bone Disorders Consortium (BBDC) includes 14 medical research sites working to better understand and treat these disorders. The consortium aims to explore the
  • Oregon Health and Science University

    When the COVID-19 pandemic hit in early 2020, traditional, in-person methods of community outreach and engagement (CE) had to be reimagined and redefined in order to accommodate new COVID-19 life-style and community needs. Through CE, the Oregon Clinical and Translational Research Institute (OCTRI) Community Research Hub works to connect and support researchers and community organizations (CBOs)

  • The Tillamook County Wellness (TCW) coalition, of which the Oregon CTSA (OCTRI) is a member and key supporter, scored a big win recently when Tillamook Adventist Health’s newly-created Community Well-Being Division absorbed TCW’s Wellness Coordinator position – as well as the person filling it – to head Adventist’s new Division. This move was an important step, because it confirms the importance

  • Oregon Health and Science University Logo
    -
    Oregon Health and Science University

    OHSU is joining forces with MIT Hacking Medicine and academic and industry partners from across the Pacific Northwest to bring you the inaugural OHSU Invent-a-thon, a virtual health hackathon, October 23–25, 2020.  MIT Hacking Medicine events have directly led to the creation of numerous successful companies, gaining over $250 million in funding, and even a billion-dollar acquisition. The ideas

  • The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects